COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,400 Articles (22,816 medRxiv, 8,584 bioRxiv)

Most recent first Previous |  Page 1183: Articles 11821-11830  | Next

SARS-CoV-2 infects human adipose tissue and elicits an inflammatory response consistent with severe COVID-19
Martinez-Colon, G. J., Ratnasiri, K., Chen, H., Jiang, S., Zanley, E., Rustagi, A., Verma, R., Chen, H., Andrews, J. R., Mertz, K., Tzankov, A., Azagury, D., Boyd, J., Nolan, G. P., Schürch, C. M., Matter, M. S., Blish, C. A., McLaughlin, T. L.
10.1101/2021.10.24.465626 — Posted: 2021-10-25
SARS-CoV-2 Infection Impacts Carbon Metabolism and Depends on Glutamine for Replication in Syrian Hamster Astrocytes
Oliveira, L. G., Angelo, Y. d. S., Yamamoto, P., Carregari, V. C., Crunfli, F., Reis-de-Oliveira, G., Costa, L., Duque, E. A., Santos, N. B., Almeida, G. M., Firmino, E. M. S., Paiva, I. M., Polonio, C. M., Zanluqui, N. G., Oliveira, M. G., Davanzo, G. G., Ayupe, M. C., Salgado, C. L., Campos, A. C. A., Goes, L. G. B., Cunha, M. P., Lima, M. R. D., Fonseca, D. M., Guimaraes, A. M. S., Minoprio, P. M., Munhoz, C. D., Mori, C. M. C., Moraes-Vieira, P. M., Cunha, T. M., Martins-de-Souza, D., Peron, J. P. S.
10.1101/2021.10.23.465567 — Posted: 2021-10-24 Discussion: Offsite
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway
Gagne, M., Corbett, K. S., Flynn, B. J., Foulds, K. E., Wagner, D. A., Andrew, S. F., Todd, J.-P. M., Honeycutt, C. C., McCormick, L., Nurmukhambetova, S. T., Davis-Gardner, M. E., Pessaint, L., Bock, K. W., Nagata, B. M., Minai, M., Werner, A. P., Moliva, J. I., Tucker, C., Lorang, C. G., Zhao, B., McCarthy, E., Cook, A., Dodson, A., Mudvari, P., Roberts-Torres, J., Laboune, F., Wang, L., Goode, A., Kar, S., Boyoglu-Barnum, S., Yang, E. S., Shi, W., Ploquin, A., Doria-Rose, N., Carfi, A., Mascola, J. R., Boritz, E. A., Edwards, D. K., Andersen, H., Lewis, M. G., Suthar, M. S., Graham, B. S., Roederer, M., Moore, I. N., Nason, M. C., Sullivan, N. J., Douek, D. C., Seder, R. A.
10.1101/2021.10.23.465542 — Posted: 2021-10-24
The humanized nanobody RBD-1-2G tolerates the spike N501Y mutation to neutralize SARS-CoV-2
Fu, Y., da Fonseca Rezende e Mello, J., Fleming, B. D., Renn, A., Chen, C. Z., Hu, X., Xu, M., Gorshkov, K., Hanson, Q., Zheng, W., Lee, E. M., Perera, L., Petrovich, R., Pradhan, M., Eastman, R. T., Itkin, Z., Stanley, T., Hsu, A., Dandey, V., Gillette, W., Taylor, T., Ramakrishnan, N., Perkins, S., Esposito, D., Oh, E., Susumu, K., Wolak, M., Ferrer, M., Hall, M. D., Borgnia, M. J., Simeonov, A.
10.1101/2021.10.22.465476 — Posted: 2021-10-24
Characterization of raloxifene as potential pharmacological agent against SARS-CoV-2 and its variants
Iaconis, D., Talarico, C., Manelfi, C., Cesta, M. C., Zippoli, M., Caccuri, F., Matusali, G., Bordi, L., Scorzolini, L., Bucci, E. M., Caruso, A., Nicastri, E., Allegretti, M., Beccari, A. R.
10.1101/2021.10.22.465294 — Posted: 2021-10-24
Inactivation of SARS Coronavirus 2 and COVID-19 patient samples for contemporary immunology and metabolomics studies
Eddins, D. J., Bassit, L. C., Chandler, J., Haddad, N. S., Musall, K., Yang, J., Kosters, A., Dobosh, B. S., Hernandez, M. R., Ramonell, R. P., Tirouvanziam, R. M., Lee, F. E.-H., Zandi, K., Schinazi, R. F., Ghosn, E.
10.1101/2021.10.22.465481 — Posted: 2021-10-24
Effect of SARS-CoV-2 infection on outcome of cancer patients: A systematic review and meta-analysis of studies of unvaccinated patients
Visci, G., Di Felice, G., Teglia, F., Angelini, M., Boffetta, P.
10.1101/2021.10.20.21265284 — Posted: 2021-10-23
Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: a descriptive cohort study among 1.1 million vaccinated people in Hong Kong
Li, X., Gao, L., Tong, X., Chan, V. K. Y., Chui, C. S. L., Lai, F., Wong, C., Wan, E. Y. F., Chan, E. W. Y., Lau, K. K., Lau, C. S., Wong, I. C. K.
10.1101/2021.10.21.21265314 — Posted: 2021-10-23
Nanoviricides Platform Technology based NV-387 polymer Protects Remdesivir from Plasma-Mediated Catabolism in vitro:Importance of its increased lifetime for in vivo action
Chakraborty, A., Diwan, A., Arora, V., Thakur, Y., Holkar, P., Chiniga, V.
10.1101/2021.10.22.465399 — Posted: 2021-10-23
Clinical characteristics of pregnant women infected with Coronavirus Disease 2019 in China: a nationwide case-control study
Li, Q., Chen, L., Jiang, H., Zheng, D., Wang, Y., Mei, J., Ma, X., Wei, Y., Zhao, Y., Qiao, J.
10.1101/2021.10.21.21265313 — Posted: 2021-10-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).